Indivior Pharmaceuticals, Inc 6-K, filed Mar 18, 2024
Indivior Pharmaceuticals, Inc. (INDV)
6-K
2024-03-18
For: 2024-03-18
View Original
Added on
April 10, 2026
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on March 18, 2024.
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date: March 18, 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ☐
|
|
EXHIBIT INDEX
|
Exhibit
No.
|
Description
of Exhibit
|
|
99.1
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Indivior PLC
|
|
Date: March
18, 2024
|
/s/
Kathryn Hudson
|
|
|
Name:
Kathryn Hudson
|
|
|
Title:
Company Secretary
|
|
|
Exhibit 99.1
INDIVIOR
PLC (THE 'COMPANY')
NOTIFICATION
AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED
WITH THEM
The
Company announces the following transactions carried out by Mark
Crossley, a PDMR and the Chief Executive of the Company on March
14, 2024, and March 15, 2024.
On March 15, 2024, an award over 19,215 Ordinary Shares of $0.10
each ('Shares') vested in favour of Mark under the Indivior
Deferred Bonus Plan 2018 (the 'DBP'). This award was granted
on March 15, 2022 and vested following the end of the two-year
deferral period. The vesting of the award was not subject to
performance conditions. The vesting of this award was settled
on a net-settled basis, resulting in the delivery of Shares in the
amount set out below.
|
Name of PDMR
|
Number of vested Shares
|
Number of Shares delivered
|
|
Mark
Crossley
|
19,215
|
10,549
|
On March 15, 2024, Mark also received 15,444 Shares, following the
exercise and net settlement of a share option. The option exercise
was in respect of an option over 42,123 Shares granted on December
29, 2014, at an option price of £5.55 per share.
On March 14, 2024, March 15, 2024 and March 18, 2024, Mark Crossley
disposed of a total of 117,197 Shares; 25,993 Shares arising from
the above transactions and 91,204 Shares from the release of vested
awards under the Indivior Long-Term Incentive Plan on March 5,
2024.
91,204 Shares were sold on March 14, 2024 at an average price of
£16.30 per share. 15,444 Shares were sold on March 15, 2024 at
an average price of £16.44 per share and 10,549 Shares were
sold on March 18, 2024 at an average price of £16.17 per
share.
Following the completion of these transactions, Mark Crossley has
an interest in 90,032 Shares in the Company.
This notification is made in accordance with the requirements
of the UK Market Abuse Regulation.
Kathryn Hudson
Company Secretary
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||
|
a)
|
Name
|
Mark
Crossley
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
Director
/ PDMR - Chief Executive Officer
|
|
|
b)
|
Initial notification /Amendment
|
Initial
notification
|
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
Indivior
PLC
|
|
|
b)
|
LEI
|
213800V3NCQTY7IED471
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Delivery
of Shares on Vesting of an award granted under the
DBP.
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
N/A
|
10,549
|
||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
|
e)
|
Date of the transaction
|
March
15, 2024
|
|
|
f)
|
Place of the transaction
|
Outside
a trading venue
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Delivery
of Shares arising from exercise of an option
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
£5.55
|
15,444
|
||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
|
e)
|
Date of the transaction
|
March
15, 2024
|
|
|
f)
|
Place of the transaction
|
Outside
a trading venue
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Sale of
Ordinary Shares
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
£16.30
|
91,204
|
||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
|
e)
|
Date of the transaction
|
March
14, 2024
|
|
|
f)
|
Place of the transaction
|
London
Stock Exchange (XLON)
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Sale of
Ordinary Shares
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
£16.44
|
15,444
|
||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
|
e)
|
Date of the transaction
|
March
15, 2024
|
|
|
f)
|
Place of the transaction
|
London
Stock Exchange (XLON)
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification
code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Sale of
Ordinary Shares
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
£16.17
|
10,549
|
||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
|
e)
|
Date of the transaction
|
March
18, 2024
|
|
|
f)
|
Place of the transaction
|
London
Stock Exchange (XLON)
|
|
Indivior PLC's Legal Entity Identifier code is
213800V3NCQTY7IED471.